Constance Ames, born in 1973, graduated with a B.S. in Accounting from the University of Maryland. She has a solid foundation in finance, which she brought to her role at Axsome Therapeutics, where she served as Vice President of Finance...

Constance Ames, born in 1973, graduated with a B.S. in Accounting from the University of Maryland. She has a solid foundation in finance, which she brought to her role at Axsome Therapeutics, where she served as Vice President of Finance until transitioning to a consulting role in 2017. Constance was instrumental during her tenure, helping the company navigate its early stages, particularly with clinical trials and regulatory approvals. Her compensation reached $696,000 in 2018, reflecting a notable bonus based on her performance metrics, which were tied to crucial company goals. Interestingly, in 2017, she opted for a consulting position that shifted her role away from any performance bonuses. This shift illustrates her strategic adaptability. While at Axsome, she had stock options granted for a total value of $261,612 in her final year, but she was not in a position to realize those through newly granted stock options as her executive role ended that year. Constance’s journey underscores the importance of finance in biotechnology as she helped steer Axsome Therapeutics through important growth phases in a highly competitive industry.